SCHEMBL21241795

SCHEMBL21241795

CN(C)Sc1cccc(C(=O)NCC(=O)Nc2nc(-c3ccc(CN)cc3)cs2)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.45
▸ LMNA P02545 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ POLB P06746 2/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ WNT3A P56704 2/20 0.42
▸ ROCK1 Q13464 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ ELOVL1 Q9BW60 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ APP P05067 1/20 0.41
▸ PRKACA P17612 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21242061 0.91 POLB (0.52) MAPTLMNASMN1; SMN2POLBKMT2A
SCHEMBL21241931 0.91 MAPT (0.55) MAPTKMT2AALDH1A1MEN1ELOVL1
SCHEMBL21241794 0.91 RAB9A (0.44) MAPTLMNASMN1; SMN2POLBKMT2A
SCHEMBL21241854 0.88 MAPT (0.48) MAPTKMT2AALDH1A1MEN1ELOVL1
SCHEMBL21241789 0.87 MAPT (0.47) MAPTSMN1; SMN2POLBKMT2AROCK1
SCHEMBL21241888 0.86 MAPT (0.40) MAPTLMNASMN1; SMN2POLBKMT2A
SCHEMBL21241981 0.84 ADORA3 (0.54) MAPTLMNASMN1; SMN2POLBKMT2A
SCHEMBL21225009 0.83 ALDH1A1 (0.51) MAPTLMNASMN1; SMN2KMT2AWNT3A
SCHEMBL21241887 0.83 SIRT5 (0.41) MAPTLMNASMN1; SMN2POLBKMT2A
SCHEMBL21241803 0.81 CSNK2A2 (0.41) LMNAKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019152437-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2019-08-08 — — WO disclosed
Send feedback